Javascript must be enabled to continue!
Erectile dysfunction as a marker and predictor of cardiovascular disease
View through CrossRef
Erectile dysfunction (ED) is defined as the inability to obtain or maintain a penile erection to support satisfactory sexual performance. It is considered an early manifestation of generalized vascular disease and recognized as a marker of increased cardiovascular risk both acutely and chronically by predicting all-cause mortality, cardiovascular mortality, coronary events, stroke, and peripheral artery disease in men with and without known coronary artery disease. The link between ED and cardiovascular disease might reside in the interaction between androgen level, chronic inflammation, and cardiovascular risk factors that determine endothelial dysfunction and atherosclerosis both in the penile and coronary circulation. Because penile artery size is smaller compared with coronary arteries, the same degree of endothelial dysfunction and atherosclerotic burden causes a more significant reduction of blood flow in erectile tissues compared with that in coronary circulation. From a clinical standpoint, because ED may precede cardiovascular disease, it can be used as an early marker to identify men at higher risk of cardiovascular events. The average 3-year time period between the onset of ED symptoms and a cardiovascular event offers the opportunity for detailed cardiological assessment and intensive treatment of risk factors.
Title: Erectile dysfunction as a marker and predictor of cardiovascular disease
Description:
Erectile dysfunction (ED) is defined as the inability to obtain or maintain a penile erection to support satisfactory sexual performance.
It is considered an early manifestation of generalized vascular disease and recognized as a marker of increased cardiovascular risk both acutely and chronically by predicting all-cause mortality, cardiovascular mortality, coronary events, stroke, and peripheral artery disease in men with and without known coronary artery disease.
The link between ED and cardiovascular disease might reside in the interaction between androgen level, chronic inflammation, and cardiovascular risk factors that determine endothelial dysfunction and atherosclerosis both in the penile and coronary circulation.
Because penile artery size is smaller compared with coronary arteries, the same degree of endothelial dysfunction and atherosclerotic burden causes a more significant reduction of blood flow in erectile tissues compared with that in coronary circulation.
From a clinical standpoint, because ED may precede cardiovascular disease, it can be used as an early marker to identify men at higher risk of cardiovascular events.
The average 3-year time period between the onset of ED symptoms and a cardiovascular event offers the opportunity for detailed cardiological assessment and intensive treatment of risk factors.
Related Results
Cardiovascular Disease in End-stage Renal Failure
Cardiovascular Disease in End-stage Renal Failure
Abstract
A better understanding of the pathophysiology of renal failure coupled with technological advances in dialysis techniques and renal transplantation have gre...
ESC Textbook of Cardiovascular Nursing
ESC Textbook of Cardiovascular Nursing
Abstract
The ESC Textbook of Cardiovascular Nursing is the official textbook of the European Society of Cardiology (ESC) Association of Cardiovascular Nursing and Al...
New Frontiers in Men's Sexual Health
New Frontiers in Men's Sexual Health
An internationally known physician presents here the most comprehensive medical information regarding normal sexual functioning and the various sexual problems that affect men, mos...
Sexual Dysfunction and Exercise (DRAFT)
Sexual Dysfunction and Exercise (DRAFT)
Sexual dysfunction often is multifactorial, with contributing etiologies ranging from cardiometabolic, neuronal, hormonal to psychological in origin. Whatever the origin, there is ...
Interoception, categorization, and symptom perception
Interoception, categorization, and symptom perception
Medical practice and the disease model importantly rely on the accuracy assumption of symptom perception: patients’ symptom reports are a direct and accurate reflection of physiolo...
Mechanisms of inflammation
Mechanisms of inflammation
This chapter provides a brief summary of the immune pathogenesis of atherosclerosis, highlighting shared features with inflammatory pathways in rheumatoid arthritis (RA) described ...
Treatment of ANCA-associated vasculitis
Treatment of ANCA-associated vasculitis
The goals of treatment in anti-neutrophil cytoplasm antibody (ANCA) vasculitis are to stop vasculitic activity, to prevent vasculitis returning, and to address longer-term comorbid...
Frontiers in Cardiovascular Drug Discovery: Volume 4
Frontiers in Cardiovascular Drug Discovery: Volume 4
Frontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on t...

